Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX - Lyseng-Williamson, K A; Plosker, G L (Pharmacoeconomics, 2007)